Skip to main content
. 2024 Oct 22;16(21):3589. doi: 10.3390/nu16213589

Table 2.

Baseline (T0) differences in demographic, clinical, and nutritional status assessment of malnourished subjects (n = 43) and non-malnourished subjects (n = 66). Data are reported as mean ± standard deviation. p-values refer to Mann–Whitney U test or chi-squared t-test.

Baseline Characteristics Malnourished
(n = 43)
Non-Malnourished
(n = 66)
p-Value
Gender, women 24 (56%) 27 (41%) 0.127
Age (years) 67 ± 12 72 ± 9 0.154
Anthropometric measurements
Weight (kg) 57 ± 10 77 ±16 <0.001 ***
Height (m) 1.64 ± 10 1.67 ± 11 0.232
BMI (kg/m2) 21.0 ± 2.3 27.3 ± 4.3 <0.001 ***
Index stroke type
Ischemic 35 (81%) 51 (77%) 0.606
Hemorrhagic 8 (19%) 15 (23%)
Affected side
Right 21 (49%) 37 (56%) 0.460
Left 22 (51%) 29 (44%)
Smoking habit (smokers and ex-smokers) 17 (40%) 33 (52%) 0.231
Comorbidities
Hypertension 32 (74%) 61 (92%) 0.009 **
Type 2 Diabetes 9 (21%) 19 (29%) 0.359
Dyslipidemia 15(35%) 30(45%) 0.273
Heart disease 4 (25%) 12 (75%) 0.200
Dysphagia 23 (53%) 26 (39%) 0.148
Cumulative Illness Rating Scale (CIRS)
CIRS severity 2.2 ± 0.4 2.2 ± 0.4 0.270
CIRS comorbidity 5.3 ± 1.9 5.0 ± 2.1 0.259
Days from stroke onset to enrollment 93 ± 51 82 ± 61 0.075
Activities of daily living (ADL) assessment
modified Barthel Index (0–100) 43 ± 20 41 ± 23 0.680
Hematochemical analyses
Glucose (mg/dL) 113 ± 45 108 ± 35 0.717
Cholesterol (mg/dL) 126 ± 41 125 ± 33 0.779
HDL cholesterol (mg/dL) 57 ± 18 49 ± 15 0.037
Ratio (cholesterol/HDL cholesterol) 2.3 ± 0.9 2.7 ± 0.9 0.059
Triglycerides (mg/dL) 113 ± 42 130 ± 66 0.138
Albumin (g/L) 3.7 ± 0.5 3.9 ± 0.4 0.020 *

* p-value < 0.05; ** p-value < 0.01; *** p-value < 0.001.